{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:19:00Z","timestamp":1707524340448},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,7,6]]},"DOI":"10.7759\/cureus.16215","type":"journal-article","created":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T17:04:48Z","timestamp":1625591088000},"source":"Crossref","is-referenced-by-count":1,"title":["Iatrogenic Iron Overload Causing Porphyria Cutanea Tarda in a Patient With a Rare Nonsense Heterozygous UROD Gene Mutation"],"prefix":"10.7759","author":[{"given":"Hallie B","family":"Anderson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael H","family":"Storandt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rekha","family":"Kallamadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dinesh","family":"Bande","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhishek","family":"Matta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2019.01.004","article-title":"Porphyria cutanea tarda: recent update","volume":"128","author":"Singal AK","year":"2019","unstructured":"Singal AK. Porphyria cutanea tarda: recent update. Mol Genet Metab. 2019, 128:271-81. 10.1016\/j.ymgme.2019.01.004","journal-title":"Mol Genet Metab"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.13580","article-title":"Porphyria cutanea tarda: an intriguing genetic disease and marker","volume":"56","author":"Handler NS","year":"2017","unstructured":"Handler NS, Handler MZ, Stephany MP, Handler GA, Schwartz RA. Porphyria cutanea tarda: an intriguing genetic disease and marker. Int J Dermatol. 2017, 56:e106-17. 10.1111\/ijd.13580","journal-title":"Int J Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/humu.35","article-title":"Seven novel point mutations in the uroporphyrinogen decarboxylase (UROD) gene in patients with familial porphyria cutanea tarda (f-PCT)","volume":"17","author":"Cappellini MD","year":"2001","unstructured":"Cappellini MD, Martinez di Montemuros F, Tavazzi D, et al.. Seven novel point mutations in the uroporphyrinogen decarboxylase (UROD) gene in patients with familial porphyria cutanea tarda (f-PCT). Hum Mutat. 2001, 17:350. 10.1002\/humu.35","journal-title":"Hum Mutat"},{"key":"ref4","article-title":"Familial Porphyria Cutanea Tarda","author":"Liu LU","year":"1993","unstructured":"Liu LU, Phillips J, Bonkovsky H. Familial Porphyria Cutanea Tarda. University of Washington, Seattle, Seattle, WA; 1993-2021."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2008.117432","article-title":"Familial and sporadic porphyria cutanea tarda: characterization and diagnostic strategies","volume":"55","author":"Aarsand AK","year":"2009","unstructured":"Aarsand AK, Boman H, Sandberg S. Familial and sporadic porphyria cutanea tarda: characterization and diagnostic strategies. Clin Chem. 2009, 55:795-803. 10.1373\/clinchem.2008.117432","journal-title":"Clin Chem"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgmr.2020.100638","article-title":"Early presentation of adult-onset conditions: a dual diagnosis of hereditary hemochromatosis and porphyria cutanea tarda","volume":"25","author":"Strong A","year":"2020","unstructured":"Strong A, Keller K, Merves J. Early presentation of adult-onset conditions: a dual diagnosis of hereditary hemochromatosis and porphyria cutanea tarda. Mol Genet Metab Rep. 2020, 25:100638. 10.1016\/j.ymgmr.2020.100638","journal-title":"Mol Genet Metab Rep"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1159\/000496492","article-title":"Iron deficiency anemia in chronic kidney disease","volume":"142","author":"Gafter-Gvili A","year":"2019","unstructured":"Gafter-Gvili A, Schechter A, Rozen-Zvi B. Iron deficiency anemia in chronic kidney disease. Acta Haematol. 2019, 142:44-50. 10.1159\/000496492","journal-title":"Acta Haematol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/kisup.2012.37","article-title":"Notice","volume":"2","year":"2012","unstructured":"Notice. Kidney Int Suppl (2011). 2012, 2.279. 10.1038\/kisup.2012.37","journal-title":"Kidney Int Suppl (2011)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/dth.12024","article-title":"Desferrioxamine treatment of porphyria cutanea tarda in a patient with HIV and chronic renal failure","volume":"27","author":"Vasconcelos P","year":"2014","unstructured":"Vasconcelos P, Luz-Rodrigues H, Santos C, Filipe P. Desferrioxamine treatment of porphyria cutanea tarda in a patient with HIV and chronic renal failure. Dermatol Ther. 2014, 27:16-8. 10.1111\/dth.12024","journal-title":"Dermatol Ther"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199002013220507","article-title":"Erythropoietin for the treatment of porphyria cutanea tarda in a patient on long-term hemodialysis","volume":"322","author":"Anderson KE","year":"1990","unstructured":"Anderson KE, Goeger DE, Carson RW, Lee SM, Stead RB. Erythropoietin for the treatment of porphyria cutanea tarda in a patient on long-term hemodialysis. N Engl J Med. 1990, 322:315-7. 10.1056\/NEJM199002013220507","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/4591871","article-title":"Porphyria cutanea tarda in a patient with end-stage renal disease: a case of successful treatment with deferoxamine and ferric carboxymaltose","volume":"2017","author":"Rodrigues N","year":"2017","unstructured":"Rodrigues N, Caeiro F, Santana A, Mendes T, Lopes L. Porphyria cutanea tarda in a patient with end-stage renal disease: a case of successful treatment with deferoxamine and ferric carboxymaltose. Case Rep Nephrol. 2017, 2017:4591871. 10.1155\/2017\/4591871","journal-title":"Case Rep Nephrol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/55536-iatrogenic-iron-overload-causing-porphyria-cutanea-tarda-in-a-patient-with-a-rare-nonsense-heterozygous-urod-gene-mutation","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:26:52Z","timestamp":1707506812000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/55536-iatrogenic-iron-overload-causing-porphyria-cutanea-tarda-in-a-patient-with-a-rare-nonsense-heterozygous-urod-gene-mutation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,6]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.16215","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7,6]]}}}